Related references
Note: Only part of the references are listed.Hepatitis B Virus Core Promoter Mutations Contribute to Hepatocarcinogenesis by Deregulating SKP2 and Its Target, p21
Yuehua Huang et al.
GASTROENTEROLOGY (2011)
Liver cancer epidemic in China: Past, present and future
Jian Guo Chen et al.
SEMINARS IN CANCER BIOLOGY (2011)
SKP2 and CKS1 Promote Degradation of Cell Cycle Regulators and Are Associated With Hepatocellular Carcinoma Prognosis
Diego F. Calvisi et al.
GASTROENTEROLOGY (2009)
The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: A longitudinal analysis
Zhong-Liao Fang et al.
JOURNAL OF HEPATOLOGY (2009)
Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis
Shijian Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller et al.
NATURE (2009)
Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdh1-mediated Skp2 destruction
Daming Gao et al.
NATURE CELL BIOLOGY (2009)
Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China
Xia Guo et al.
JOURNAL OF HEPATOLOGY (2008)
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
Hwai-I Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP:: tipping the scales of cancer
David Frescas et al.
NATURE REVIEWS CANCER (2008)
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels
M-F Yuen et al.
GUT (2008)
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
Y-C Chou et al.
GUT (2008)
A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis
J. W. Jang et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma
Yasuhito Tanaka et al.
JOURNAL OF HEPATOLOGY (2006)
Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: A case-control study
Chun-Jen Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines
Tomoyuki Sakamoto et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression
Paraskevi A. Farazi et al.
CANCER RESEARCH (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
T1653 mutation in the box a increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection
K Ito et al.
CLINICAL INFECTIOUS DISEASES (2006)
Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells
K Harada et al.
ORAL ONCOLOGY (2005)
RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells
F Jiang et al.
ONCOGENE (2005)
Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells
SH Lee et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene
HJ Kwun et al.
NUCLEIC ACIDS RESEARCH (2004)
Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage
YH Hsieh et al.
CARCINOGENESIS (2004)
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study
MF Yuen et al.
CARCINOGENESIS (2004)
The enigmatic X gene of hepatitis B virus
MJ Bouchard et al.
JOURNAL OF VIROLOGY (2004)
Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma
GY Hwang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Prevalence of HBV precore/core promoter variants in the United States
CJ Chu et al.
HEPATOLOGY (2003)
HBXIP functions as a cofactor of survivin in apoptosis suppression
H Marusawa et al.
EMBO JOURNAL (2003)
Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants
S Parekh et al.
JOURNAL OF VIROLOGY (2003)
Skp2 regulates Myc protein stability and activity
SY Kim et al.
MOLECULAR CELL (2003)
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers
JH Kao et al.
GASTROENTEROLOGY (2003)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
Molecular pathogenesis of human hepatocellular carcinoma
SS Thorgeirsson et al.
NATURE GENETICS (2002)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Hepatitis B virus X protein increases expression of p21Cip-1/WAF1/MDA6 and p27Kip-1 in primary mouse hepatocytes, leading to reduced cell cycle progression
L Qiao et al.
HEPATOLOGY (2001)
Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw
AK Tsubota et al.
JOURNAL OF MEDICAL VIROLOGY (2001)
Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions
CR Madden et al.
JOURNAL OF VIROLOGY (2001)
Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway
WL Shih et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1→S transition via a p53-independent pathway in human hepatoma cells
US Park et al.
ONCOGENE (2000)
Share Paper
